Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 40 Records) |
| Query Trace: Neoplasms and PDCD1[original query] |
|---|
| Association of programmed death-1 gene polymorphisms with the risk of basal cell carcinoma. International journal of immunogenetics 2019 Jul . Fathi Farshid, Ebrahimi Milad, Eslami Asma, Hafezi Hossein, Eskandari Nahid, Motedayyen Hosse |
| Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma. Frontiers in microbiology 2019 10 475. De Re Valli, Tornesello Maria Lina, De Zorzi Mariangela, Caggiari Laura, Pezzuto Francesca, Leone Patrizia, Racanelli Vito, Lauletta Gianfranco, Gragnani Laura, Buonadonna Angela, Vaccher Emanuela, Zignego Anna Linda, Steffan Agostino, Buonaguro Franco |
| PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2 Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Aug . Guarneri Valentina, Dieci Maria Vittoria, Bisagni Giancarlo, Brandes Alba A, Frassoldati Antonio, Cavanna Luigi, Musolino Antonino, Giotta Francesco, Rimanti Anita, Garrone Ornella, Bertone Elena, Cagossi Katia, Nanni Oriana, Piacentini Federico, Orvieto Enrico, Griguolo Gaia, Curtarello Matteo, Urso Loredana, Paré Laia, Chic Nuria, D'Amico Roberto, Prat Aleix, Conte PierFran |
| An Immunogenomic Investigation of Oral Cavity Squamous Cell Carcinoma in Patients Aged 45?Years and Younger. The Laryngoscope 2020 4 131 (2): 304-311. Maroun Christopher A, Zhu Gangcai, Fakhry Carole, Gourin Christine G, Seiwert Tanguy Y, Vosler Peter S, Tan Marietta, Koch Wayne, Eisele David W, Pardoll Drew M, Mandal Rajar |
| Prognostic value and immunological role of PDCD1 gene in pan-cancer. International immunopharmacology 2020 Oct 89 (Pt B): 107080. Miao Yandong, Wang Jiangtao, Li Qiutian, Quan Wuxia, Wang Yingying, Li Chen, Wu Jingjing, Mi Dengh |
| Identification of four gastric cancer subtypes based on genetic analysis of cholesterogenic and glycolytic pathways. Bioengineered 2021 8 12 (1): 4780-4793. Zhu Zhou, Qin Jian, Dong Chencheng, Yang Jin, Yang Maughan, Tian Jana, Zhong Xiaoga |
| TGFBR2 mutation predicts resistance to immune checkpoint inhibitors in patients with non-small cell lung cancer. Therapeutic advances in medical oncology 2021 8 13 17588359211038477. Li Teng, Wang Han, Xu Jiachen, Li Chengcheng, Zhang Yudong, Wang Guoqiang, Liu Yutao, Cai Shangli, Fang Wenfeng, Li Junling, Wang Zhij |
| Increased PD-1 Level in Severe Cervical Injury Is Associated With the Rare Programmed Cell Death 1 (PDCD1) rs36084323 A Allele in a Dominant Model. Frontiers in cellular and infection microbiology 2021 7 11 587932. da Silva Mauro César, Medeiros Fernanda Silva, da Silva Neila Caroline Henrique, Paiva Larissa Albuquerque, Gomes Fabiana Oliveira Dos Santos, Costa E Silva Matheus, Gomes Thailany Thays, Peixoto Christina Alves, Rygaard Maria Carolina Valença, Menezes Maria Luiza Bezerra, Welkovic Stefan, Donadi Eduardo Antônio, Lucena-Silva Nor |
| Comprehensive Analysis of the Immune-Oncology Targets and Immune Infiltrates of N -Methyladenosine-Related Long Noncoding RNA Regulators in Breast Cancer. Frontiers in cell and developmental biology 2021 7 9 686675. Zhang Xiaoqiang, Shen Li, Cai Ruyu, Yu Xiafei, Yang Junzhe, Wu Xian, Zhu Yanhui, Liu Xiao |
| Development of an Oncogenic Driver Alteration Associated Immune-Related Prognostic Model for Stage I-II Lung Adenocarcinoma. Frontiers in oncology 2021 2 10 593022. Xu Jian-Zhao, Gong Chen, Xie Zheng-Fu, Zhao H |
| Protumorigenic Role of Elevated Levels of DNA Polymerase Epsilon Predicts an Immune-Suppressive Microenvironment in Clear Cell Renal Cell Carcinoma. Frontiers in genetics 2021 12 12 751977. Wu Xiaohui, Tang Haijia, Xu Wen-Hao, Tang Haidan, Wei Shiyin, Anwaier Aihetaimujiang, Huang Haineng, Qu Yuan-Yuan, Zhang Hailiang, Zhao Shuai, Li Hui, Liu Wangrui, Chen Hongjing, Ding Chen, Ye Dingw |
| Tumor-Infiltrating Immune-Related Long Non-Coding RNAs Indicate Prognoses and Response to PD-1 Blockade in Head and Neck Squamous Cell Carcinoma. Frontiers in immunology 2021 11 12 692079. Ma Ben, Jiang Hongyi, Luo Yi, Liao Tian, Xu Weibo, Wang Xiao, Dong Chuanpeng, Ji Qinghai, Wang |
| H2AFZ Is a Prognostic Biomarker Correlated to TP53 Mutation and Immune Infiltration in Hepatocellular Carcinoma. Frontiers in oncology 2021 11 11 701736. Dong Mingwei, Chen Jing, Deng Yiran, Zhang Danying, Dong Ling, Sun Dalo |
| Programmed Death Ligand 2 Gene Polymorphisms Are Associated With Lung Adenocarcinoma Risk in Female Never-Smokers. Frontiers in oncology 2021 11 753788. Liang Sheng-Kai, Chien Li-Hsin, Chang Gee-Chen, Tsai Ying-Huang, Su Wu-Chou, Chen Yuh-Min, Huang Ming-Shyan, Lin Hsien-Chih, Fang Wen-Tsen, Hung Hsiao-Han, Jiang Shih-Sheng, Chen Chih-Yi, Chen Kuan-Yu, Chang I-Shou, Hsiung Chao A, Chen Chien-Jen, Yang Pan-Chyr, |
| A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer. Frontiers in immunology 2021 1 11 590618. Wu Xiangkun, Lv Daojun, Cai Chao, Zhao Zhijian, Wang Ming, Chen Wenzhe, Liu Yong |
| Programmed cell death 1 (PDCD1) gene haplotypes and susceptibility of patients to basal cell carcinoma. Molecular biology reports 2021 Jan . Fathi Farshid, Zamani Batool, Piroozmand Ahmad, Mozafarpoor Samaneh, Seyedhashemi Effat, ArefNezhad Reza, Motedayyen Hosse |
| Clinical significance and immune landscape of KIR2DL4 and the senescence-based signature in cutaneous melanoma. Cancer science 2022 7 113 (11): 3947-3959. Mao Rui, Ren Zhengyun, Yang Fan, Yang Peng, Zhang Tongto |
| Single-Nucleotide Polymorphisms Within Non-HLA Regions Are Associated With Engraftment Effectiveness for Patients With Unrelated Cord Blood Transplantation. Frontiers in immunology 2022 13 888204. Chen Ding-Ping, Jaing Tang-Her, Hour Ai-Ling, Lin Wei-Tzu, Hsu Fang-Pi |
| Association between the side effect induced by COVID-19 vaccines and the immune regulatory gene polymorphism. Frontiers in immunology 2022 11 13 941497. Chen Ding-Ping, Wen Ying-Hao, Lin Wei-Tzu, Hsu Fang-Pi |
| PD1.5 variant on PDCD1 gene, regulator of T lymphocyte activity, influences non-muscle-invasive bladder cancer risk. American journal of clinical and experimental urology 2022 10 10 (5): 334-340. Gomez Gabriela Vilas Bôas, Longhi Larissa Nara Alegrini, Saito Helena Paes Almeida, Lourenço Gustavo Jacob, Dos Reis Rodolfo Borges, Tobias Machado Marcos, Reis Leonardo Oliveira, Denardi Fernandes, Lima Carmen Silvia Pass |
| LCK and CD3E Orchestrate the Tumor Microenvironment and Promote Immunotherapy Response and Survival of Muscle-Invasive Bladder Cancer Patients. Frontiers in cell and developmental biology 2022 1 9 748280. Zheng Xiaonan, Liao Xinyang, Nie Ling, Lin Tianhai, Xu Hang, Yang Lu, Shen Bairong, Qiu Shi, Ai Jianzhong, Wei Qia |
| The PD-1 single-nucleotide polymorphism rs11568821 and rs2227981 as a novel prognosis model in a triple-negative breast cancer patient. Molecular biology reports 2023 5 . Katarzyna Boguszewska-Byczkiewicz, Thomas Wow, Bo?ena Szyma?ska, Micha? Kosny, Agnieszka Kolacinska-W |
| Development and validation of metabolic models for predicting survival and immune status of hepatocellular carcinoma patients. Advances in clinical and experimental medicine : official organ Wroclaw Medical University 2023 5 . Xueying Li, Mengli Gu, Qiying Hu, Yihui Weng, Xianlei C |
| Common inherited variants of PDCD1, CD274 and HAVCR2 genes differentially modulate the risk and prognosis of adenocarcinoma and squamous cell carcinoma. Journal of cancer research and clinical oncology 2023 2 . Moksud Nafeesa, Wagner Marta, Pawe?czyk Konrad, Por?bska Irena, Muszczy?ska-Bernhard Beata, Kowal Aneta, Wi?niewski Andrzej, Kosacka Monika, Ko?czak Julia, Karpi?ski Pawe?, Frydryk Dominik, Andrzejczak Anna, Karabon Lidia, Ku?nierczyk Piotr, Jasek Moni |
| Comprehensive characterization of MUC16 mutations in lung adenocarcinoma for immunotherapies and prognosis: An observational study. Medicine 2023 11 102 (44): e35481. Tingjun Liu, Lianlian Wu, Jing Liu, Hao Chen, Bao Zhu, Dandan Qiao, Yuhua Zhu, Tingya Liu, Quangang Chen, Ankang |
| A circadian clock gene-related signature for predicting prognosis and its association with sorafenib response in hepatocellular carcinoma. Translational cancer research 2023 11 12 (10): 2493-2507. Qing Liang, Yongqing Ye, Enze Li, Jingming Fan, Jinglin Gong, Jiaxin Ying, Yawen Cao, Rongqi Li, Ping Wa |
| Tumoral programmed cell death 1 (PD1) expression in endometrial carcinoma is a prognostic marker for patient outcome. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2024 7 . Barin Feroz, Teresa L Pan, Katharina Leitner, Christoph Ebner, Katharina Steger, Wanja Kildal, Gunnar Kristensen, Alain Gustave Zeimet, Hubert Hackl, Heidi Fiegl, Christian Marth, Verena Wies |
| A heterogeneous tumor immune microenvironment of uncommon epidermal growth factor receptor mutant non-small cell lung cancer. Cancer science 2024 6 . Chong Zhang, Liangwei Yang, Weidi Zhao, Huangkai Zhu, Shuo Shi, Songan Chen, Guoqiang Wang, Bing Li, Guofang Zh |
| Loss of Y in regulatory T lymphocytes in the tumor micro-environment of primary colorectal cancers and liver metastases. Scientific reports 2024 4 14 (1): 9458. Magdalena Wójcik, Ulana Juhas, Elyas Mohammadi, Jonas Mattisson, Kinga Dr??ek-Chy?a, Edyta Rychlicka-Buniowska, Bo?ena Bruhn-Olszewska, Hanna Davies, Katarzyna Chojnowska, Pawe? Olszewski, Micha? Bie?kowski, Micha? Jankowski, Olga Rostkowska, Andrzej Hellmann, Rafa? P?ksa, Jacek Kowalski, Marek Zdrenka, Jarek Kobiela, Wojciech Zegarski, Wojciech Biernat, ?ukasz Szylberg, Piotr Remiszewski, Jakub Mieczkowski, Natalia Filipowicz, Jan P Dumans |
| A study of the association of vitamin D receptor (VDR) as a predictive biomarker for immune checkpoint inhibitor therapy with immune invasion in colon adenocarcinoma. Journal of pharmaceutical and biomedical analysis 2024 10 252 116510. Guanqun Chao, Ailing Lin, Yang B |
- Page last reviewed:Feb 1, 2024
- Content source: